XBiotech Inc. — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2020-09-01

Reporting Person: HAN QUEENA (VP Finance & HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-01	Common Stock	M	30000	$4.24	Acquired	30000	Direct
2020-09-01	Common Stock	M	27692	$4.16	Acquired	57692	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-01	Stock Option	$4.24	M	30000	Disposed	2027-06-19	Common Stock (30000)	Direct
2020-09-01	Stock Option	$4.16	M	27692	Disposed	2028-05-08	Common Stock (27692)	Direct